Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXR8JO
|
||||
| Drug Name |
benzyl (S)-1-((S)-1-cyano-2-(4-methoxyphenyl)ethylamino)-4-methyl-1-oxopentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL207081
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H29N3O4
|
||||
| Canonical SMILES |
COc1ccc(C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc2ccccc2)C#N)cc1
|
||||
| InChI |
InChI=1S/C24H29N3O4/c1-17(2)13-22(27-24(29)31-16-19-7-5-4-6-8-19)23(28)26-20(15-25)14-18-9-11-21(30-3)12-10-18/h4-12,17,20,22H,13-14,16H2,1-3H3,(H,26,28)(H,27,29)/t20-,22-/m0/s1
|
||||
| InChIKey |
MBRJRDMYBURHPH-UNMCSNQZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.